ABSTRACT
Este estudo buscou verificar possíveis alterações sistêmicas causadas pelo flúor administrado em diferentes concentrações. Foi utilizado um modelo de estudo animal, no qual foram selecionados 60 rattus norvegicus, aleatoriamente divididos em 4 grupos, sendo três grupos testes (receberam água fluoretada nas concentrações de 0,7 ppm F; 1,2 ppm F e 2,0 ppm F), e um grupo controle que recebeu água destilada. Para análise histomorfológica por microscopia óptica, os ratos foram submetidos a dissecação dos seguintes órgãos: intestino alto (duodeno), rim e fígado. Os resultados obtidos após a avaliação descritiva comparativa dos grupos de estudo evidenciaram alterações morfológicas em todos os grupos testes, concluindo, desta forma, que o flúor administrado, nestas concentrações, pode ser tóxico.
This study sought to verify possible systemic changes caused by fluoride administered at different concentrations. An animal model was used in which 60 rattus norvegicus were randomly divided into 4 groups, with three test groups receiving fluoridated water at the different concentrations (0.7 ppm F, 1.2 ppm F and 2, 0 ppm F), and a control group receiving distilled water. A histomorphological analysis was performed by light microscopy after the dissection of the following rat organs: the large intestine (duodenum), the kidney and the liver. The results obtained after the comparative descriptive evaluation of the study groups showed morphological changes in all the test groups, concluding that the fluoride administered at these concentrations could be toxic.
ABSTRACT
This investigation compared gingival crevicular fluid (GCF) interleukin-1β (IL-1β) concentrations in periodontitis patients subjected to a strict supragingival biofilm control (Supra) for 6 months. Never-smokers (23) and smokers (n = 20; 19.6 ± 11.8 cigarettes/day) moderate-to-severe chronic periodontitis patients underwent a 6 months period of supragingival control with weekly recall visits. Periodontal probing depth (PPD), bleeding on probing (BOP) and GCF samples (from different PPD category sites: 3-5 mm and 6–10 mm) were obtained at the baseline, 30, and 180 days. IL-1β was assessed by enzyme-linked immunosorbent assay. Generalized estimating equations were used to fit prediction models of IL-1β changes, considering the dependence between the examinations, and using only data from experimental sites. Overall IL-1β concentrations decreased from 3.2 pg/µL to 1.9 pg/µL. Higher baseline IL-1β concentrations were associated with higher baseline PPD values in both groups. There were no differences in IL-1β concentrations between never-smokers and smokers over time for any PPD category. Higher baseline PPD values and the presence of BOP on day 180 were significantly associated with higher IL-1β concentrations. A strict Supra regimen reduced IL-1β concentrations over time in periodontitis patients. The benefits observed for smokers underline the importance of oral hygiene measures, even considering the presence of this important risk factor.